130 related articles for article (PubMed ID: 15557723)
21. Carvedilol and nebivolol improve left ventricular systolic functions in patients with non-ischemic heart failure.
Karabacak M; Doğan A; Tayyar Ş; Özaydın M; Erdoğan D
Anatol J Cardiol; 2015 Apr; 15(4):271-6. PubMed ID: 25413223
[TBL] [Abstract][Full Text] [Related]
22. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
[TBL] [Abstract][Full Text] [Related]
23. Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?
Cioffi G; De Feo S; Pulignano G; Del Sindaco D; Tarantini L; Stefenelli C; Opasich C
Int J Cardiol; 2006 Feb; 107(2):220-4. PubMed ID: 16412800
[TBL] [Abstract][Full Text] [Related]
24. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure.
Del Sindaco D; Pulignano G; Cioffi G; Tarantini L; Di Lenarda A; De Feo S; Opasich C; Minardi G; Giovannini E; Leggio F
J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):675-82. PubMed ID: 17700396
[TBL] [Abstract][Full Text] [Related]
26. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
Lowes BD; Tsvetkova T; Eichhorn EJ; Gilbert EM; Bristow MR
Int J Cardiol; 2001 Dec; 81(2-3):141-9. PubMed ID: 11744130
[TBL] [Abstract][Full Text] [Related]
27. Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure.
Macdonald PS; Keogh AM; Aboyoun C; Lund M; Amor R; McCaffrey D
Heart; 1999 Nov; 82(5):589-93. PubMed ID: 10525515
[TBL] [Abstract][Full Text] [Related]
28. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction.
Takeda Y; Fukutomi T; Suzuki S; Yamamoto K; Ogata M; Kondo H; Sugiura M; Shigeyama J; Itoh M
Am J Cardiol; 2004 Aug; 94(4):448-53. PubMed ID: 15325927
[TBL] [Abstract][Full Text] [Related]
29. Replacement of carvedilol for propranolol in patients with heart failure.
Marques F; Castro RB; Nobre F; Pintya AO; Gallo L; Maciel BC; Simões MV
Arq Bras Cardiol; 2010 Jul; 95(1):107-14. PubMed ID: 20563524
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol.
Guazzi M; Agostoni P; Matturri M; Pontone G; Guazzi MD
Am Heart J; 1999 Sep; 138(3 Pt 1):460-7. PubMed ID: 10467196
[TBL] [Abstract][Full Text] [Related]
31. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial.
Cleland JG; Pennell DJ; Ray SG; Coats AJ; Macfarlane PW; Murray GD; Mule JD; Vered Z; Lahiri A;
Lancet; 2003 Jul; 362(9377):14-21. PubMed ID: 12853194
[TBL] [Abstract][Full Text] [Related]
32. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
Sanderson JE; Chan SK; Yip G; Yeung LY; Chan KW; Raymond K; Woo KS
J Am Coll Cardiol; 1999 Nov; 34(5):1522-8. PubMed ID: 10551702
[TBL] [Abstract][Full Text] [Related]
33. Effects of carvedilol on heart rate dynamics in patients with congestive heart failure.
Ridha M; Mäkikallio TH; Lopera G; Pastor J; de Marchena E; Chakko S; Huikuri HV; Castellanos A; Myerburg RJ
Ann Noninvasive Electrocardiol; 2002 Apr; 7(2):133-8. PubMed ID: 12049685
[TBL] [Abstract][Full Text] [Related]
34. Carvedilol produces sustained long-term benefits: follow-up at 12 years.
MacGregor JF; Wachter SB; Munger M; Stoddard G; Bristow MR; Gilbert EM
Congest Heart Fail; 2009; 15(1):5-8. PubMed ID: 19187400
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic effects of dobutamine in patients with an exacerbation of chronic systolic heart failure treated with low doses of carvedilol.
Triposkiadis F; Dalampiras P; Kelepeshis G; Skoularigis J; Sitafidis G
Int J Clin Pharmacol Ther; 2008 Mar; 46(3):136-9. PubMed ID: 18397684
[TBL] [Abstract][Full Text] [Related]
36. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.
Palazzuoli A; Bruni F; Puccetti L; Pastorelli M; Angori P; Pasqui AL; Auteri A
Eur J Heart Fail; 2002 Dec; 4(6):765-70. PubMed ID: 12453548
[TBL] [Abstract][Full Text] [Related]
37. Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment.
Azeka E; Franchini Ramires JA; Valler C; Alcides Bocchi E
J Am Coll Cardiol; 2002 Dec; 40(11):2034-8. PubMed ID: 12475466
[TBL] [Abstract][Full Text] [Related]
38. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
39. Carvedilol: a review of its use in chronic heart failure.
Keating GM; Jarvis B
Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089
[TBL] [Abstract][Full Text] [Related]
40. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
Maack C; Elter T; Nickenig G; LaRosee K; Crivaro M; Stäblein A; Wuttke H; Böhm M
J Am Coll Cardiol; 2001 Oct; 38(4):939-46. PubMed ID: 11583862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
